We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
C7, an easy mistake to make or you were subconsciously wishing Mr Diggle WAS our chairman!
Besides, some here have mixed up Mr Diggle with officer Dibble lol.
Now that would be some BOD - Top Cat, Officer Dibble and Benny the Ball!
Thank you Bermuda,
Indeed I was mixing up with Chiplin and Diggle.
Have a good day.
Chelsea,
Priority Review Vouchers are awarded by the FDA to companies developing drugs for rare paediatric diseases . If the FDA approves an NDA for that drug then the company can either sell voucher or use it for future drugs of their own.
As the name suggests, the voucher entitles the owner to priority review when it comes to approval. The review period is shortened to 6 months. Only a handful are handed out each year by the FDA and as AstraZeneca have shown today, big pharmaceutical companies are prepared to pay tens of millions to buy vouchers to use with their own drugs because it speeds up the time taken to get their drug to market.
Re. your question on the AGM - I don't know but think you may be confusing John Chiplin and Martin Diggle. I believe JC has moved back to the UK.
Bermuda, good evening, a couple of questions there. I saw the RNS from AZ this morning, they actually had two, what does a company have to show to get a voucher like that? As you say it sounds bonkers but literlly they give you what appears to be $95m to do with as you please? must be more to it than that.
As far as logistics did we not read a rumour that Martin Diggle is considering relocating to the U.K. for a period of time? or was that just wishful thinking?
Crumbs, I can only imagine Glenthorne is happy with the Vulpes investment, it certainly moved the share and IMHO won"t be the last time.
Yes, I see at least not at this stage any negatives to the Diggles being in and having real skin in the game too... An observation is John Glencross (calculus) has remained silent on them coming in or indeed on any recent scancell news on his twitter feed It would be interesting to know his thoughts and wonder has he spoken to Diggle since and possibly before him coming on board ( I presume so )
Deadly,
Who knows whether any study centres have actually opened for recruitment and started screening patients yet? In fact who knows how many study centres there are, where they are or who the study investigators are? All we know is that Prof. Poulam Patel is now Principal Investigator so I guess it's possible that they're concentrating on just getting Nottingham up and running. There is no sign of the trial yet on any of the clinical trial registers or on the NHS clinical trail portal.
As for AGM, I'm pretty sure the only reason the AGM is early this year is likely to be down to nothing more than logistics. It can't be an easy task to coordinate diaries especially with AL based in USA and I believe MD lives in South Africa. Perhaps one of them are off on some exotic holiday later on? Who knows but I really don't think that it's down to any Scancell related reason.
Finally, noticed your post re. AstraZeneca's RNS this morning and their purchase of a Priority Review Voucher for $95m. Another AIM bio I'm invested in has been granted a Priority Review Voucher for its phase III drug. Market cap of about £35m but holding a priority review voucher it may be about to sell for around $100m - bonkers isn't it?
Crumbs, lol, yes he will. Were the options for him set at about 22p......I can"t remember now.
Martin Diggle isn"t underwater though, and I am pretty sure on agreeing his first stake, plans were put into place for the next issuanceor taking into account any commercial deals that are likely. No, I think we are in very good hands now, there was a gaping space for someone of Diggles experience and financial knowledge for some time. I think that has been filled and we as a company will see the benefits of that very soon. Take care.
And I guess knowing the SCIB1 trial is starting very soon and the MOD1 trial will be following that just makes me think about going forward now and not lingering in some past issues.
Probably the biggest factor in how I feel is Martin Diggle and the Vulpes investment. They spent an awful lot of time and research, not to mention pretty thorough due digilance before deciding on taking a 16.67% stake in us, as a long term investment. I always said the BOD were talking with such certainty that they knew the investment was coming when it did, and I do believe the next round Vulpes will be a significant player too. Yes the cynics will play on the 5p they paid, but I think their timing came about from last August when the market knew City Financial were in deep trouble, albeit we as a BB didn"t pick up on that. Ruck correctly made a point to me about not making Vulpes sound like the Messiah valuable partnership, for the long term, and I choose to believe they know a lot more than we do. Hopefully at the AGM much more will be revealed, and i just feel investor confidence will rise significantly. So I am more than happy on that basis to find out more and rather than "wrath" I do want to make a point about communication in the future. Rather than seeing it as going back, I feel we can all benefit from a vast improvement in that area.
As I said I do know where you are coming from, we will soon find out, but with what lies ahead I think we all have a lot to look forward too, and just being back in human trials will make such a difference, it seems a lifetime ago when we were last in that position.
Anyway have a good weekend, the weather is set fair, and time for a much needed chill out i guess for many. ATB
Well Chippers is underwater and will be feeling our pain :)...... unless of course, something is coming along to change that pre-AGM
Tend to agree Deadly, but LTH do have trading pots too. My last buys were £6k at around 7.50 back in February, I not only wanted more shares but it brought my average down considerably.
Tell me something, and I"m interested in all opinions, but going back to the placings at 10p and 12p, I understand by what we know now, why we are sitting around where we are now, albeit I don"t think it will be very long until we are back to those levels at least.
@C7 - I would argue that the majority of attendees who go to AGMs are long term holders, and therefore in Scancells case, underwater.
Deadly, now that is what I call speculation, lol. Interesting comment you make........................
.P.S. point i was trying to make is that they would risking he wrath from (some) investors if the SP is still languishing around the 7p at the time of the AGM. (And yes languishing is the appropriate word here IMO)
Well that is your opinion so it is a worthy one, I just wonder though, we have doubled since the SP hit 3.6p, there will be many who have topped up, sliced or just lowered their averages. As a LTH who didn"t buy or sell during that period I was just relieved we hit 10p, however briefly after seeing City Financial sell for 3p just a couple of months earlier. IMHO as I said yesterday I think we will rise to 8p+ around the time of the AGM, MMs are not exactly having an easy task getting shares ATM and as far as a deal with SCIB goes, I have a few replies from RG and CH, one of which I posted up yesterday and the thrust of all communications with the BOD are how important it is to gather data. To me that sounds as if we have interest in Immunobody, dependant on the data from the combo trial, and the same could easily apply to MOD1.
So, I don"t think they will face any wrath, pretty convinced IMHO we will hear patients dosed by the AGM, and as long as we feel confident in future timelines and direction of the company, not withstanding some input from Martin Diggle, I feel we will be content just to know we are on the right course for a far better SP performance in the months to come. Well thats how i feel, and after 7 years here, well I am relieved that we could have 3 trials running in 2020. ATB
typo "...would be risking the wrath..."
....P.S. point i was trying to make is that they would risking he wrath from (some) investors if the SP is still languishing around the 7p at the time of the AGM. (And yes languishing is the appropriate word here IMO)
Or they called it early so people didn't have enough time to plan a journey/day off, i.e. want a low turnout? I'm not sure what the minimum amount of notice is needed for an AGM? (My preference is still the Roche multi-billion buyout mind you.)
Start of the trial: Should we assume it has actually started? If we go by the pro-active article "Scancell to begin UK arm of phase II skin cancer trial ‘immediately’", it clearly states that. https://www.proactiveinvestors.co.uk/companies/news/901014/scancell-to-begin-uk-arm-of-phase-ii-skin-cancer-trial-immediately-901014.html
Also still intrigued by the earlier than usual AGM. As Ruckrover posted Tue 16:24 "Re the early date:They possibly have some good news they want to get out as soon as they can but want it to coincide with the AGM so as to deflect some of the expected criticism's" Now this seems the most likely thing as they know they will be some expected (and deserved IMO) animosity/criticism. But what news could it be??? Could it be the trial starting? Although that doesn't tie in with "immediately". Could it be BionTech news? etc?
Or as ratcliffewrtitter (Tue 13:33) suggested, only semi-jokingly I'd like to think :): "One of the reasons for having the AGM conspicuously early is no doubt to get approval for a multi-billon pound sell-off of the SCIB platform to Roche"...why not that!?